Literature DB >> 22511178

Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.

Sabina Rinaldi1, Mauro Lise, Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, Gwenaelle Guillas, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Annekatrin Lukanova, Rudolf Kaaks, Manuela M Bergmann, Heiner Boeing, Antonia Trichopoulou, Dimosthenis Zylis, Elissavet Valanou, Domenico Palli, Claudia Agnoli, Rosario Tumino, Silvia Polidoro, Amalia Mattiello, H Bas Bueno-de-Mesquita, Petra H Peeters, Elisabete Weiderpass, Eiliv Lund, Guri Skeie, Laudina Rodríguez, Noemie Travier, Maria-José Sánchez, Pilar Amiano, José-María Huerta, Eva Ardanaz, Torgny Rasmuson, Göran Hallmans, Martin Almquist, Jonas Manjer, Konstantinos K Tsilidis, Naomi E Allen, Kay-Tee Khaw, Nick Wareham, Graham Byrnes, Isabelle Romieu, Elio Riboli, Silvia Franceschi.   

Abstract

Results from case-control and prospective studies suggest a moderate positive association between obesity and height and differentiated thyroid carcinoma (TC). Little is known on the relationship between other measures of adiposity and differentiated TC risk. Here, we present the results of a study on body size and risk of differentiated TC based on a large European prospective study (EPIC). During follow-up, 508 incident cases of differentiated TC were identified in women, and 58 in men. 78% of cases were papillary TC. Cox proportional hazard models were used to estimate hazard ratios (HRs). In women, differentiated TC risk was significantly associated with body mass index (BMI, kg/m(2)) (HR highest vs lowest quintile = 1.41, 95% CI: 1.03-1.94); height (HR = 1.61; 95% CI: 1.18-2.20); HR highest vs lowest tertile waist (HR = 1.34, 95% CI: 1.00-1.79) and waist-to-hip ratio (HR = 1.42, 95% CI: 1.05-1.91). The association with BMI was somewhat stronger in women below age 50. Corresponding associations for papillary TC were similar to those for all differentiated TC. In men the only body size factors significantly associated with differentiated TC were height (non linear), and leg length (HR highest vs. lowest tertile = 3.03, 95% CI: 1.30-7.07). Our study lends further support to the presence of a moderate positive association between differentiated TC risk and overweight and obesity in women. The risk increase among taller individuals of both sexes suggests that some genetic characteristics or early environmental exposures may also be implicated in the etiology of differentiated TC.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22511178     DOI: 10.1002/ijc.27601

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

1.  Obesity and thyroid cancer: is leptin the (only) link?

Authors:  Antonio Di Cristofano
Journal:  Endocrinology       Date:  2013-08       Impact factor: 4.736

2.  Electric Blanket Use and Risk of Thyroid Cancer in the Women's Health Initiative Observational Cohort.

Authors:  Ikuko Kato; Alicia Young; Jingmin Liu; Judith Abrams; Cathryn Bock; Michael Simon
Journal:  Women Health       Date:  2015-05-21

3.  Meta-analysis in the association between obesity and risk of thyroid cancer.

Authors:  Wei Zhang; Xiyong Bai; Huai'e Ge; Haibin Cui; Zhijiang Wei; Guoda Han
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Rising incidence of thyroid cancer in Serbia.

Authors:  N Slijepcevic; V Zivaljevic; I Paunovic; A Diklic; Perisic Zivkovic; D Miljus; A Grgurevic; S Sipetic
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

5.  Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies.

Authors:  Cari M Kitahara; Marjorie L McCullough; Silvia Franceschi; Sabina Rinaldi; Alicja Wolk; Gila Neta; Hans Olov Adami; Kristin Anderson; Gabriella Andreotti; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Francoise Clavel-Chapelon; Lisa A De Roo; Yu-Tang Gao; J Michael Gaziano; Graham G Giles; Niclas Håkansson; Pamela L Horn-Ross; Vicki A Kirsh; Martha S Linet; Robert J MacInnis; Nicola Orsini; Yikyung Park; Alpa V Patel; Mark P Purdue; Elio Riboli; Kimberly Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Arthur B Schneider; Howard D Sesso; Xiao-Ou Shu; Pramil N Singh; Piet A van den Brandt; Elizabeth Ward; Elisabete Weiderpass; Emily White; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Patricia Hartge; Amy Berrington de González
Journal:  Thyroid       Date:  2016-02       Impact factor: 6.568

6.  Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules.

Authors:  Mario Rotondi; Maria Grazia Castagna; Carlo Cappelli; Cristina Ciuoli; Francesca Coperchini; Francesco Chiofalo; Fabio Maino; Paola Palmitesta; Luca Chiovato; Furio Pacini
Journal:  Eur Thyroid J       Date:  2016-04-27

7.  Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.

Authors:  Mustafa Akker; Sibel Güldiken; Tammam Sipahi; Orkide Palabıyık; Ayhan Tosunoğlu; Özlem Çelik; Nermin Tunçbilek; Atakan Sezer; Necdet Süt
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

8.  Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study.

Authors:  Camilla Præstegaard; Susanne K Kjær; Jane Christensen; Anne Tjønneland; Jytte Halkjær; Allan Jensen
Journal:  J Invest Dermatol       Date:  2014-10-07       Impact factor: 8.551

9.  Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.

Authors:  Li Xu; Matthias Port; Stefano Landi; Federica Gemignani; Monica Cipollini; Rossella Elisei; Lilia Goudeva; Jörg Andreas Müller; Kai Nerlich; Giovanni Pellegrini; Christoph Reiners; Cristina Romei; Robert Schwab; Michael Abend; Erich M Sturgis
Journal:  Thyroid       Date:  2014-05-05       Impact factor: 6.568

10.  Body mass index and incidence of thyroid cancer in Korea: the Korean Cancer Prevention Study-II.

Authors:  Hyun-Young Shin; Yong Ho Jee; Eo Rin Cho
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-23       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.